Methods for treating psychosis associated with interferson-α therapy
AssigneeCorcept Therapeutics, Inc.
InventorJoseph K. Belanoff
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of psychosis associated with interferon-α therapy by administering an amount of a glucocorticoid receptor antagonist effective to ameliorate the symptoms of psychosis in the patient, wherein the patient is not otherwise in need of treatment with a glucocorticoid receptor antagonist. The present invention further relates to kits for the treatment of Hepatitis C infection in a patient.
Claims19
A method of ameliorating the symptoms of psychosis associated with interferon α therapy in a patient, comprising:
- administering to the patient having received interferon α therapy and suffering from psychosis associated with the interferon α therapy, an amount of a glucocorticoid receptor antagonist effective to ameliorate the symptoms of psychosis in the patient, with the proviso that the patient is not otherwise in need of treatment with a glucocorticoid receptor antagonist.
The method of claim. 1, wherein the patient is suffering from chronic myelogenous leukemia, HIV, Human T-Cell Lymphotropic Virus or cancer.
Dependencies are inferred from the claim text.